iifl-logo-icon 1

Windlas Biotech Ltd Share Price

901.2
(-0.57%)
Sep 6, 2024|03:32:05 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open904.5
  • Day's High928
  • 52 Wk High929
  • Prev. Close906.35
  • Day's Low895.25
  • 52 Wk Low311.6
  • Turnover (lac)561.28
  • P/E31.73
  • Face Value5
  • Book Value221.92
  • EPS28.5
  • Mkt. Cap (Cr.)1,883.54
  • Div. Yield0
View All Historical Data
No Records Found

Windlas Biotech Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

904.5

Prev. Close

906.35

Turnover(Lac.)

561.28

Day's High

928

Day's Low

895.25

52 Week's High

929

52 Week's Low

311.6

Book Value

221.92

Face Value

5

Mkt Cap (₹ Cr.)

1,883.54

P/E

31.73

EPS

28.5

Divi. Yield

0

Windlas Biotech Ltd Corporate Action

2 Aug 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

17 Aug 2023

12:00 AM

BookCloser

arrow

16 Aug 2023

12:00 AM

AGM

Announcement Date: 16 Aug, 2023

arrow

5 May 2023

12:00 AM

Dividend

Dividend Amount: 4

Record Date: 05 Sep, 2023

arrow

Windlas Biotech Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Windlas Biotech Ltd SHAREHOLDING SNAPSHOT

08 Sep, 2024|03:57 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 62.51%

Foreign: 0.00%

Indian: 62.51%

Non-Promoter- 11.93%

Institutions: 11.93%

Non-Institutions: 25.55%

Custodian: 0.00%

Share Price

Windlas Biotech Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

10.4

10.46

10.9

6.41

Preference Capital

0

0

0

0

Reserves

439.89

392.2

384.23

192.58

Net Worth

450.29

402.66

395.13

198.99

Minority Interest

View Balance Sheet
Loading...

No Record Found

View Profit & Loss
Loading...

No Record Found

View Cash Flow
Loading...

No Record Found

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

630.96

513.08

465.93

427.6

328.85

Excise Duty

0

0

0

0

0

Net Sales

630.96

513.08

465.93

427.6

328.85

Other Operating Income

0

0

0

0

0

Other Income

13.47

9.97

6.71

8.74

2.49

Windlas Biotech Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,824.55

157.34,37,806.65237.820.744,409.7498.75

Divis Laboratories Ltd

DIVISLAB

5,137.8

81.931,36,080.524300.582,063507.93

Cipla Ltd

CIPLA

1,611.05

33.11,31,478.831,055.940.83,752.25346.4

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,416.7

77.521,16,513.074690.812,394201.77

Zydus Lifesciences Ltd

ZYDUSLIFE

1,100

25.691,12,205.151,700.80.274,035.4156.19

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Windlas Biotech Ltd

Management

Register Office

Registrar Office

Chairman & Independent Directo

Vivek Dhariwal

Whole-time Director

Ashok Kumar Windlass

Managing Director

Hitesh Windlass

Joint Managing Director

Manoj Kumar Windlass

Executive Director

Pawan Kumar Sharma

Non-Exec & Non-Independent Dir

Prachi Jain Windlass

Non-Exec. & Independent Dir.

Srinivasan Venkataraman

Non-Exec. & Independent Dir.

Gaurav Gulati

Company Sec. & Compli. Officer

Ananta Narayan Panda

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Windlas Biotech Ltd (formerly known as Windlas Biotech Private Limited) was incorporated in the year 2001. The Company provides pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers around the world.The company has state-of-the-art manufacturing plant facilities located in Dehradun, Uttarakhand, India. It also has a sales force and distribution network spread across 14 states. The company market its own manufactured authentic nutraceutical, pharmaceutical and Ayurvedic products to serve the semi-urban and rural communities at affordable prices. Apart from this, the company has three distinct strategic business verticals (SBVs) mainly comprising of CDMO services and products; domestic trade generics and over-the-counter (OTC) brands; and exports.The company provides a comprehensive range of CDMO services ranging from product discovery, product development, licensing and commercial manufacturing of generic products, including complex generics, in compliance with current Good Manufacturing Practices (GMP) with a focus on improved safety, efficacy and cost. In addition to this, it sells its own branded products in the trade generics and OTC markets as well as export generic products to several countries. Moreover, the company has significant experience in developing and manufacturing generic fixed dose combinations. Its focus has currently been in launching new complex generic products in
Read More

Company FAQs

What is the Windlas Biotech Ltd share price today?

Down Arrow

The Windlas Biotech Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹901.2 today.

What is the Market Cap of Windlas Biotech Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Windlas Biotech Ltd is ₹1883.54 Cr. as of 06 Sep ‘24

What is the PE and PB ratio of Windlas Biotech Ltd?

Down Arrow

The PE and PB ratios of Windlas Biotech Ltd is 31.73 and 4.20 as of 06 Sep ‘24

What is the 52 Week High and Low of Windlas Biotech Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Windlas Biotech Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Windlas Biotech Ltd is ₹311.6 and ₹929 as of 06 Sep ‘24

What is the CAGR of Windlas Biotech Ltd?

Down Arrow

Windlas Biotech Ltd's CAGR for 5 Years at 17.36%, 3 Years at 32.03%, 1 Year at 133.75%, 6 Month at 65.71%, 3 Month at 42.28% and 1 Month at 14.95%.

What is the shareholding pattern of Windlas Biotech Ltd?

Down Arrow

The shareholding pattern of Windlas Biotech Ltd is as follows:
Promoters - 62.51 %
Institutions - 11.94 %
Public - 25.55 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020
  • Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
  • Pay 20% upfront margin of the transaction value to trade in cash market segment.
  • Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.
  • Check your Securities / MF / Bonds in the consolidated account statement issued by NSDL/CDSL every month.
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp